1. BRAF, KRAS and PIK3CA Mutation and Sensitivity to Trastuzumab in Breast Cancer Cell Line Model

Volume 18, Issue 8, August 2017, Pages 2209-2213

Satyajit Patra; Vanesa Young; Leslie Llewellyn; Jitendra Senapati; Jesil Mathew

• View Article
• PDF 312.71 K

2. Value of KRAS, BRAF, and PIK3CA Mutations and Survival Benefit from Systemic Chemotherapy in Colorectal Peritoneal Carcinomatosis

Volume 17, Issue 2, February 2016, Pages 539-543

• View Article
• PDF 560.1 K

3. The BRAFT1799A Mutation is not Associated with Occult Contralateral Carcinoma in Patients with Unilateral Papillary Thyroid Microcarcinoma

Volume 16, Issue 7, July 2015, Pages 2947-2951

• View Article
• PDF 430.1 K

4. Somatic Mutations of K-Ras and BRAF in Thai Colorectal Cancer and their Prognostic Value

Volume 14, Issue 1, January 2013, Pages 329-332

• View Article
• PDF 393.9 K